Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways

BACKGROUND: Pancreatic cancer is generally characterized with high levels of malignancy and poor prognosis. In addition, there are currently no effective therapeutic agents against the disease. However, apatinib which is a small molecular agent targeting the vascular endothelial growth factor recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yuan, Jing, Jiayu, Shi, Yu, Zhang, Pengchuang, Dong, Danfeng, Wu, Yinying, Dong, Xuyuan, Li, Enxiao, Fan, Yangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798633/
https://www.ncbi.nlm.nih.gov/pubmed/35116637
http://dx.doi.org/10.21037/tcr-21-207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798633/
https://www.ncbi.nlm.nih.gov/pubmed/35116637
http://dx.doi.org/10.21037/tcr-21-207

Ejemplares similares